Retinal imaging technology has potential in detecting Alzheimer's

Article

Medical retinal imaging company Optos found that monitoring the peripheral section of the retina could play a vital role in the detection of Alzheimer's Dementia (AD).

Medical retinal imaging company Optos found that monitoring the peripheral section of the retina could play a vital role in the detection of Alzheimer's Dementia (AD).

The investigation was part of 20 positive clinical studies announced at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) held in Fort Lauderdale, Florida, USA, 1–4 May.

A team led by Dr Tunde Peto et al., Moorfield's Eye Hospital, London, captured optomap retinal images of 102 patients (56 AD sufferers and 46 age-matched controls) to determine whether a simple eye exam could be used for screening purposes. Optos ultra wide field images were used during the screen test to identify drusen within the retina.

The findings demonstrated a high correlation between AD and peripheral, small, hard drusen formation. This suggests that examining the peripheral section of the retina could be an essential part of detecting and examining the progression of AD.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.